Skip to main content
European Commission logo print header

Identification and validation of molecular targets for pharmacological treatment of alcohol dependence (TARGALC)

Objetivo

Proposal aim is to identify novel targets for pharmacological treatment of alcoholism. In an integrative approach, complementary expertise of 5 laboratories is applied. Pharmacologically validated animal models are adapted for generation of tissue from key brain regions. RNA is purified, and gene expression profiles established using Affymetrix methodology. An expression database is constructed, and mining the database identifies candidate genes differentially expressed in the functional models. Candidates are prioritised on the basis of available knowledge and availability of pharmacological tools, and confirmed using real time PCR and in site hybridisation. Confirmed targets are fed back into the functional models, where pharmacological and molecular manipulations of targets are evaluated for their ability to block alcohol drinking and reinstatement. Validated targets are patented and provide seeds for drug development.

Convocatoria de propuestas

Data not available

Régimen de financiación

CSC - Cost-sharing contracts

Coordinador

KAROLINSKA INSTITUTE
Aportación de la UE
Sin datos
Dirección
Huddinge University Hospital
141 86 HUDDINGE
Suecia

Ver en el mapa

Coste total
Sin datos

Participantes (4)